| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.023 | 0.7 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.021 | 0.7 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.7 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.066 | 0.7 |